EFFECT OF CO-ADMINISTRATION OF URACIL OR CYTOSINE ON THE ANTI-TUMOR ACTIVITY OF CLINICAL DOSES OF 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL AND LEVEL OF 5-FLUOROURACIL IN RODENTS

被引：0

|

作者：

FUJII, S

KITANO, S

IKENAKA, K

SHIRASAKA, T

机构：

来源：

GANN | 1979年 / 70卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：209 / 214

页数：6

相关论文

共 50 条

[21] Augmentation of the chemotherapeutic effectiveness of UFT, a combination of Tegafur [1-(2-tetrahydrofuryl)-5-fluorouracil] with uracil, by oral l-leucovorin
Okabe, H
Toko, T
Saito, H
Nakano, K
Fujioka, A
Yuasa, C
Takeda, S
Unemi, N
ANTICANCER RESEARCH, 1997, 17 (1A) : 157 - 164
[22] PHYSICAL-PROPERTIES OF PYRIMIDINE AND PURINE ANTIMETABOLITES .2. PERMEATION OF 5-FLUOROURACIL AND 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL THROUGH CELLOPHANE, COLLAGEN, AND SILICONE MEMBRANES
NAKANO, M
ARAKAWA, Y
JUNI, K
ARITA, T
CHEMICAL & PHARMACEUTICAL BULLETIN, 1976, 24 (11) : 2716 - 2722
[23] INHIBITION BY 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL IN COMBINATION WITH URACIL OF HEPATOCARCINOGENESIS INDUCED BY 3'-METHYL-4-DIMETHYLAMINOAZOBENZENE IN RATS
SAKAMOTO, S
HIRAI, H
TAGA, H
UCHIKOSHI, T
SUNAGA, T
ENDO, Y
KUDO, H
KATO, T
KASAHARA, N
KUWA, K
OKAMOTO, R
ANTICANCER RESEARCH, 1991, 11 (02) : 561 - 566
[24] PREVENTION OF ANTI-TUMOR EFFECT OF 5-FLUOROURACIL BY HYPOXANTHINE
YOSHIDA, M
HOSHI, A
KURETANI, K
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (24) : 2979 - 2982
[25] IN-VIVO F-19 NMR COMPARATIVE-STUDY OF 5-FLUOROURACIL, 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL (FT) AND AN FT-URACIL COADMINISTRATION SYSTEM IN MOUSE-TUMORS
KANAZAWA, Y
KUROGI, S
SHINOHARA, S
NODA, Y
MASUDA, K
CHEMICAL & PHARMACEUTICAL BULLETIN, 1994, 42 (04) : 774 - 778
[26] INTERACTION OF 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL WITH SODIUM POLY-ALPHA, L-GLUTAMATE
NISHIDA, K
ANDO, Y
MOCHINAGA, N
COLLOID AND POLYMER SCIENCE, 1981, 259 (03) : 350 - 353
[27] A PROTEIN-BOUND POLYSACCHARIDE IMMUNOMODULATOR, PSK, DOES NOT SUPPRESS THE CONVERSION FROM 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL TO 5-FLUOROURACIL IN PATIENTS WITH GASTRIC-CANCER
ANAI, H
SAKAGUCHI, Y
EMI, Y
KOHNOE, S
MAEHARA, Y
SUGIMACHI, K
ANTI-CANCER DRUGS, 1991, 2 (03) : 275 - 278
[28] STUDIES ON COMBINATION THERAPY WITH 1-(TETRAHYDRO-2-FURANYL)-5-FLUOROURACIL PLUS URACIL .2. EFFECTS OF URACIL ON INVITRO METABOLISMS OF 1-(TETRAHYDRO-2-FURANYL)-5-FLUOROURACIL AND 5-FLUOROURACIL
UNEMI, N
TAKEDA, S
CHEMOTHERAPY-TOKYO, 1981, 29 (02): : 176 - 184
[29] SYNTHESIS AND ANTI-TUMOR ACTIVITY OF AN ACYCLONUCLEOSIDE DERIVATIVE OF 5-FLUOROURACIL
ROSOWSKY, A
KIM, SH
WICK, M
JOURNAL OF MEDICINAL CHEMISTRY, 1981, 24 (10) : 1177 - 1181
[30] Serum factors attenuating the anti-tumor activity of 5-fluorouracil
Miwa, M
Kojima, T
Naruse, T
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2001, 16 (04) : 317 - 322

← 1 2 3 4 5 →